FERNLEY, Nev.--(BUSINESS WIRE)--Verify Smart Corporation (VSMR) a Global innovator in financial fraud
prevention and digital distribution solutions announced today that it
has signed a Letter of Intent to acquire an equity stake and exclusive
international reseller rights in Med-Con Technologies, LLC for cash and
stock.

Med-Con Technologies provides a patented solution (MedSkedTM
) for improved medication adherence. MedSkedTM gives patients
the ability to more effectively self-manage and keep track of their
daily medication dosing. Med-Con’s solutions are effectively assisting
patients in over thirty two countries, and twenty four languages.

Med-Con has also developed MedCon Mobile Smart LabelTM which
is a mobile based patient adherence solution for the Pharmaceutical
industry and is currently being tested by a major Pharmaceutical company
with other pilots scheduled. The cloud based SaaS software manages the
patient’s medication dosing schedule via a mobile device while sending
vital adherence data to the Pharmaceutical clinical trial teams for
analysis via the MedCon CentralTM data portal. Verify Smart
and Med-Con believe this product is groundbreaking and a huge first to
market play in the Pharmaceutical space.

Pharmaceutical Manufacturing Magazine said “Medication Adherence is
arguably the largest problem in healthcare, it is estimated that
medication non-adherence causes 30 – 50% of treatment failures and
125,000 deaths annually. The direct cost to healthcare is estimated as
high as $289 billion annually. Pharmaceutical companies are motivated to
increase adherence because higher compliance equates to better treatment
effectiveness and overall better patient health...and of course, higher
drug sales.”

Tony Cinotti, President of Verify Smart said “Verify Smart will work
closely with Med-Con Technologies to establish Verify Smart as the
exclusive international reseller of MedSked and MedCon Mobile Smart
Label for Pharmaceutical Companies, Pharmacy chains and Specialty
Pharmacy markets. Verify Smart will also, in parallel, build an
additional adherence solution specifically for Retail Pharmacies. This
will greatly increase Med-Con sales worldwide. Pharmacy customers taking
prescription medications can now have the same benefits as Med-Con’s
corporate adherence solutions.”

Anthony Londino, President of Med-Con Technologies commented “We are
excited about working with Verify Smart to develop new products and
broaden our reach into new markets and opportunities. Verify Smart’s
sales and marketing expertise, IT partners and extensive contacts in the
retail pharmacy space will provide Med-Con with the additional resources
to become the world leader in medication adherence and remote patient
monitoring data.”

ABOUT VERIFY SMART CORPORATION

Verify Smart Corp is an international technology company that develops
and markets innovative solutions for the global digital market. The
company also licenses patented technology for the prevention of
debit/credit card and electronic transaction fraud. The company is
expanding into the growing digital and mobile sector and will market
innovative solutions for Pharmaceutical Companies, Consumer Brands,
Educational Institutions and the Sports and Entertainment industries.

Med-Con Technologies LLC is a global provider of medication adherence
solutions and services to the pharmaceutical market. Med-Con
Technologies LLC has been helping some of the world’s most prominent
pharmaceutical companies to provide medication adherence support to
their clinical trial and commercial patients. The company is expanding
into the growing digital and mobile sector and has recently launched its MedSked
Mobile Smart Label platform, a novel and innovative patient
compliance solution.